Saito Yuichi, Nagae Genta, Motoi Noriko, Miyauchi Eisaku, Ninomiya Hironori, Uehara Hirofumi, Mun Mingyon, Okumura Sakae, Ohyanagi Fumiyoshi, Nishio Makoto, Satoh Yukitoshi, Aburatani Hiroyuki, Ishikawa Yuichi
Division of Pathology, The Cancer Institute, Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Cancer Sci. 2016 Mar;107(3):320-5. doi: 10.1111/cas.12876. Epub 2016 Feb 19.
Methylation is closely involved in the development of various carcinomas. However, few datasets are available for small cell lung cancer (SCLC) due to the scarcity of fresh tumor samples. The aim of the present study is to clarify relationships between clinicopathological features and results of the comprehensive genome-wide methylation profile of SCLC. We investigated the genome-wide DNA methylation status of 28 tumor and 13 normal lung tissues, and gene expression profiling of 25 SCLC tissues. Following unsupervised hierarchical clustering and non-negative matrix factorization, gene ontology analysis was performed. Clustering of SCLC led to the important identification of a CpG island methylator phenotype (CIMP) of the tumor, with a significantly poorer prognosis (P = 0.002). Multivariate analyses revealed that postoperative chemotherapy and non-CIMP were significantly good prognostic factors. Ontology analyses suggested that the extrinsic apoptosis pathway was suppressed, including TNFRSF1A, TNFRSF10A and TRADD in CIMP tumors. Here we revealed that CIMP was an important prognostic factor for resected SCLC. Delineation of this phenotype may also be useful for the development of novel apoptosis-related chemotherapeutic agents for treatment of the aggressive tumor.
甲基化与多种癌症的发生发展密切相关。然而,由于新鲜肿瘤样本稀缺,小细胞肺癌(SCLC)的相关数据集较少。本研究旨在阐明SCLC临床病理特征与全基因组甲基化谱综合结果之间的关系。我们研究了28个肿瘤肺组织和13个正常肺组织的全基因组DNA甲基化状态,以及25个SCLC组织的基因表达谱。在进行无监督层次聚类和非负矩阵分解后,进行了基因本体分析。SCLC聚类导致重要地识别出肿瘤的一种CpG岛甲基化表型(CIMP),其预后明显较差(P = 0.002)。多变量分析显示术后化疗和非CIMP是显著的良好预后因素。本体分析表明,CIMP肿瘤中的外在凋亡途径受到抑制,包括TNFRSF1A、TNFRSF10A和TRADD。在此我们揭示CIMP是切除的SCLC的一个重要预后因素。描绘这种表型可能也有助于开发用于治疗侵袭性肿瘤的新型凋亡相关化疗药物。